SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-17-000115
Filing Date
2017-08-08
Accepted
2017-08-08 16:31:03
Documents
4
Period of Report
2017-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k8817items202502801.htm 8-K 27206
2 EXHIBIT 10.1 ex101consultingagreement.htm EX-10.1 66655
3 EXHIBIT 99.1 ex991pressrelease.htm EX-99.1 171338
4 ptclogoimage.jpg GRAPHIC 6428
  Complete submission text file 0001070081-17-000115.txt   275550
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 171015232
SIC: 2834 Pharmaceutical Preparations